rg-hrv16
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2013 (NCT01769573)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Human rhinovirus 16Immunity, active
Human rhinovirus 16 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- rg-hrv16
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03508479 | Phase 1 | Jun 30, 2018 | University of North Carolina at Chapel Hill |
| NCT01769573 | Phase 1 | Jul 1, 2013 | University of Wisconsin |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of North Carolina at Chapel Hill | Academic/Hospital | 1 | 1 | 1 | 2018 |
| University of Wisconsin | Academic/Hospital | 1 | 1 | 1 | 2013 |
2 organizations
Page 1 / 1